Reorganization of DCRD Unlikely To Affect PMA/510(K) Review Times - FDA

The Center for Devices and Radiological Health's reoganization of the Division of Cardiovascular and Respiratory Devices, which will be complete by early September, is not expected to result in review time delays for premarket approval application and 510(k) submissions.

More from Archive

More from Medtech Insight